Evidence map›Paper›PMID 40430723›Full record

ArticlePathogens (Basel, Switzerland)2025

Microbiological Risks to Health Associated with the Release of Antibiotic-Resistant Bacteria and β-Lactam Antibiotics Through Hospital Wastewater.

Andres E Nolasco-Rojas, Eder Cruz-Del-Agua, Clemente Cruz-Cruz, Miguel Ángel Loyola-Cruz, Benjamín A Ayil-Gutiérrez, María C Tamayo-Ordóñez, Yahaira de J Tamayo-Ordoñez, Araceli Rojas-Bernabé, Francisco A Tamayo-Ordoñez, Emilio M Durán-Manuel and 10 more

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Andres E Nolasco-RojasHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0009-0005-7069-8015
Eder Cruz-Del-AguaHospital Juárez de México, Mexico City 07760, Mexico.
Clemente Cruz-CruzHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0003-1555-3102
Miguel Ángel Loyola-CruzHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0001-5383-8737
Benjamín A Ayil-GutiérrezSECIHTI-Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Biotecnología Vegetal, Reynosa 88710, Mexico.
María C Tamayo-OrdóñezLaboratorio de Ingeniería Genética, Departamento de Biotecnología, Facultad de Ciencias Químicas, Universidad Autónoma de Coahuila, Saltillo 25280, Mexico.ORCID 0000-0003-0201-0184
Yahaira de J Tamayo-OrdoñezLaboratorio de Biotecnología Ambiental del Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa 88710, Mexico.
Araceli Rojas-BernabéSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0002-3851-5881
Francisco A Tamayo-OrdoñezFacultad de Química, Universidad Autónoma del Carmen, Ciudad del Carmen 24180, Mexico.
Emilio M Durán-ManuelHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0001-8985-486X
Marianela Paredes-MendozaDivisión de Tecnología Ambiental, Universidad Tecnológica de Nezahualcóyotl, Nezahualcóyotl 57000, Mexico.ORCID 0000-0002-9383-3882
Laura M Márquez-ValdelamarLaboratorio de Secuenciación Genómica, LaNaBio, Instituto de Biología, UNAM, Mexico City 04510, Mexico.
Carlos A Jiménez-ZamarripaSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0002-9195-746X
Esther Ocharan-HernándezSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.
Paola B Zárate-SeguraSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0002-5639-9503
Omar García-HernándezDivisión de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 54090, Mexico.ORCID 0000-0001-8807-1353
Oscar Sosa-HernándezHospital Juárez de México, Mexico City 07760, Mexico.
Enzo Vásquez-JiménezHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0003-0205-817X
Claudia C Calzada-MendozaSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico.ORCID 0000-0002-5893-8566
Juan M Bello-LópezHospital Juárez de México, Mexico City 07760, Mexico.ORCID 0000-0002-9957-3807

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital wastewater (HWW) is a major source of microbiological contamination, often released into the municipal sewage system without prior treatment. This HWW may contain pathogens with antimicrobial resistance, posing risks to public health. The aim of this work was to assess the risks associated with the seasonal release of ESKAPE bacteria resistant to β-lactam antibiotics and the release of carbapenems and cephalosporins through HWW of Hospital Juárez de México. The 12-month seasonal variation in β-lactam-resistant bacterial populations was assessed in the HWW of five discharge points. Resistant isolates were identified by mass spectrometry (MALDI-TOF) coupled with PCR assays to search for antimicrobial resistance genes, while β-lactamic antibiotics were detected using high-performance liquid chromatography (HPLC). Finally, a double-entry Vester matrix was constructed to classify the problems of HWW according to their degree of causality. Seasonal differences in bacterial loads were observed, with higher levels in warmer months. A wide variety of resistant pathogens were identified, including ESKAPE bacteria, as well as emerging bacteria carrying β-lactamase-encoding genes. The release of meropenem was detected most commonly, followed by cefepime and ceftazidime. The Vester matrix allowed the identification of critical clinical and environmental scenarios where two discharge points contribute significantly to the spread of microbiological contamination. This study highlights the importance of proper management of HWW and the need for stricter regulations to reduce the risks associated with the release of resistant pathogens with health impacts.

Indexed as

Anti-Bacterial AgentsBacteriabeta-Lactam Resistancebeta-LactamsWastewaterbeta Lactam AntibioticsHospitalsHumansMexicoSeasonsAnti-Bacterial Agentsbeta Lactam Antibioticsbeta-LactamsWastewaterantibioticsantimicrobial resistanceESKAPE bacteriahospital wastewater

Identifiers

PMID40430723
PMCPMC12114504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.